Nipradilol Protects Rat Retinal Ganglion Cells from Apoptosis Induced by Serum Deprivation In Vitro and by Diabetes In Vivo

REFERENCES

• Quigley H A, Nickells R W, Kerrigan L A, Pease M E, Thibault D J, Zack D J. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995; 36: 774–786
   PubMed Web of Science ®Google Scholar
• Kerrigan L A, Zack D J, Quigley H A, Smith S D, Pease M E. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol. 1997; 115: 1031–1035
   PubMed Web of Science ®Google Scholar
• Barber A J, Lieth E, Khin S A, Antonetti D A, Buchanan A G, Gardner T W. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest. 1998; 102: 783–791
   PubMed Web of Science ®Google Scholar
• Pease M E, McKinnon S J, Quigley H A, Kerrigan-Baumrind L A, Zack D J. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci. 2000; 41: 764–774
   PubMed Web of Science ®Google Scholar
• Ino-ue M, Zhang L, Naka H, Kuriyama H, Yamamoto M. Polyol metabolism of retrograde axonal transport in diabetic rat large optic nerve fiber. Invest Ophthalmol Vis Sci. 2000; 41: 4055–4058
   PubMed Web of Science ®Google Scholar
• Caldwell R B, Bartoli M, Behzadian M A, El-Remessy A EB, Al-Shabrawey M, Platt D H, Caldwell R W. Vascular endothelial growth factor and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev. 2003; 19: 442–455
   PubMed Web of Science ®Google Scholar
• Tezel G. Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequences. Prog Retin Eye Res. 2006; 25: 490–513
   PubMed Web of Science ®Google Scholar
• Vorwerk C K, Gorla M S, Dreyer E B. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy. Surv Ophthalmol 1999; 43(Suppl 1)S142–S150
   PubMedGoogle Scholar
• Kowluru R A, Engerman R L, Case G L, Kern T S. Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int 2001; 38: 385–390
   PubMed Web of Science ®Google Scholar
• McKinnon S J, Lebman D M, Kerrigan-Baumrind L A, Merges C A, Pease M E, Kerrigan D F, Ransom N L, Tahzib N G, Reitsamer H A, Leukovitch-Verbin H, Quigley H A, Zack D J. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci. 2002; 43: 1077–1087
   PubMed Web of Science ®Google Scholar
• Barber A J, Antonetti D A, Kern T S, Reiter C EN, Soans R S, Krady J K, Levinson S W, Gardner T W, Bronson S K. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 2005; 46: 2210–2218
   PubMed Web of Science ®Google Scholar
• Uchida Y, Nakamura M, Shimizu S, Shirasawa Y, Fujii M. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent. Arch Int Pharmacodyn Ther 1983; 262: 132–149
   PubMedGoogle Scholar
• Ohira A, Wada Y, Fujii M, Nakamura M, Kasuya Y, Hamada Y, Shigenobu K. Effects of nipradilol (K-351) on alpha-adrenoceptor mediated responses in various isolated tissues. Arch Int Pharmacodyn Ther. 1985; 278: 61–71
   PubMedGoogle Scholar
• Kanno M, Araie M, Koibuchi H, Masuda K. Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans. Br J Ophthalmol 2000; 84: 293–299
   PubMed Web of Science ®Google Scholar
• Okamura T, Kitamura Y, Uchiyama M, Toda M, Ayajiki K, Toda N. Canine retinal arterial and arteriolar dilatation induced by nipradilol, a possible glaucoma therapeutic. Pharmacology. 1996; 53: 302–310
   PubMed Web of Science ®Google Scholar
• Hayashi T, Yamada K, Esaki T, Muto E, Iguchi A. The beta adrenoceptor antagonist, nipradilol, preserves the endothelial nitric oxide response in atherosclerotic vessels in rabbit. Life Sci 1997; 61: 1379–1387
   PubMed Web of Science ®Google Scholar
• Mizuno K, Koide T, Saito N, Fujii M, Nagahara M, Tomidokoro A, Tamaki Y, Araie M. Topical nipradilol: Effect on optic nerve head circulation in humans and periocular distribution in monkeys. Invest Ophthalmol Vis Sci 2002; 43: 3243–3250
   PubMed Web of Science ®Google Scholar
• Kashiwagi K, Iizuka Y, Tsukahara S. Neuroprotective effect of nipradilol on purified cultured retinal ganglion cells. J Glaucoma 2002; 11: 231–238
   PubMed Web of Science ®Google Scholar
• Mizuno K, Koide T, Yoshimura M, Araie M. Neuroprotective effect and intraocular penetration of nipradilol, a β -blocker with nitric oxide donative action. Invest Ophthalmol Vis Sci. 2001; 42: 688–694
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Tomita H, Yamaguchi K, Sato Y, Shimura M, Kuwahara S, Tamai M. Neuroprotective effect of nipradilol on axotomized rat retinal ganglion cells. Curr Eye Res 2002; 24: 114–122
   PubMed Web of Science ®Google Scholar
• Taniai M, Sato E, Mizota A, Adachi-Usami E. Protective action of nipradilol against ischemia-induced retinal damage in rats. Ophthalmic Res. 2002; 34: 331–337
   PubMed Web of Science ®Google Scholar
• Tomita H, Nakazawa T, Sugano E, Abe T, Tamai M. Nipradilol inhibits apoptosis by preventing the activation of caspase-3 via S-nitrosylation and the cGMP-dependent pathway. Eur J Pharmacol. 2002; 452: 263–268
   PubMed Web of Science ®Google Scholar
• Nagai-Kusuhara A, Nakamura M, Mukuno H, Kanamori A, Negi A, Seigel G M. cAMP-responsive element binding protein mediates a cGMP/protein kinase G-dependent anti-apoptotic signal induced by nitric oxide in retinal neuro-glial progenitor cells. Exp Eye Res. 2007; 84: 152–162
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy R R, Agarwal P, Prasanna G, Vopat K, Lambert W, Sheedlo H J, Pang I H, Shade D, Wordinger R J, Yorio T, Clark A F, Agarwal N. Characterization of a transformed rat retinal ganglion cell line. Mol Brain Res 2001; 86: 1–12
   PubMedGoogle Scholar
• Charles I, Khalyfa A, Kumar D M, Krishnamoorthy R R, Roque R S, Cooper N, Agarwal N. Serum deprivation induces apoptotic cell death of transformed rat retinal ganglion cells via mitochondrial signaling pathways. Invest Ophthalmol Vis Sci 2005; 46: 1330–1338
   PubMed Web of Science ®Google Scholar
• Maher P, Hanneken A. The molecular basis of oxidative stress-induced cell death in an immortalized retinal ganglion cell line. Invest Ophthalmol Vis Sci 2005; 46: 749–757
   PubMed Web of Science ®Google Scholar
• Zeng X X, Ng Y K, Ling E A. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 2000; 17: 463–471
   PubMed Web of Science ®Google Scholar
• Martin P M, Roon P, Van Ells T K, Ganapathy V, Smith S B. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 2004; 45: 3330–3336
   PubMed Web of Science ®Google Scholar
• Ning X, Baoyu Q, Yuzhen L, Shuli S, Reed E, Li Q Q. Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retina. Int J Mol Med 2005; 13: 87–92
   Web of Science ®Google Scholar
• Cheung A K, Fung M K, Lo A C, Lam T T, So K F, Chung S S, Chung S K. Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 2005; 54: 3119–3125
   PubMed Web of Science ®Google Scholar
• Gastinger M J, Sign R SJ, Barber A J. Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci. 2006; 47: 3143–3150
   PubMed Web of Science ®Google Scholar
• Nakanishi Y, Nakamura M, Mukuno H, Kanamori A, Seigel G M, Negi A. Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44/p42 mitogen-activated protein kinase. Exp Eye Res 2006; 83: 1108–1117
   PubMed Web of Science ®Google Scholar
• Barber A J, Nakamura M, Wolpert E B, Reiter C EN, Seigel G M, Antonetti D A, Gardner T W. Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of capase-3. J Biol Chem 2001; 276: 32814–32821
   PubMed Web of Science ®Google Scholar
• Nakamura M, Barber A J, Antonetti D A, LaNoue K F, Robinson K A, Buse M G, Gardner T W. Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem. 2001; 276: 43748–43755
   PubMed Web of Science ®Google Scholar
• Mukuno H, Nakamura M, Kanamori A, Nagai A, Negi A, Seigel G M. Unoprostone isopropyl rescues retinal progenitor cells from apoptosis in vitro. Curr Eye Res 2004; 29: 457–464
   PubMed Web of Science ®Google Scholar
• Kanamori A, Nakamura M, Mukuno H, Maeda H, Negi A. Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure. Curr Eye Res. 2004; 28: 47–54
   PubMed Web of Science ®Google Scholar
• Kanamori A, Nakamura M, Nakanishi Y, Nagai A, Mukuno H, Yamada Y, Negi A. Akt is activated via insulin/IGF-1 receptor in rat retina with episcleral vein cauterization. Brain Res. 2004; 1022: 195–204
   PubMed Web of Science ®Google Scholar
• Beckman J S, Koppenol W H. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am J Physiol. 1996; 271: C1424–C1437
   PubMed Web of Science ®Google Scholar
• Wink D A, Mitchell J B. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radical Biol Med 1998; 25: 434–456
   PubMed Web of Science ®Google Scholar
• Fiscus R R. Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neuronal cells. Neurosignals 2002; 11: 175–190
   PubMedGoogle Scholar
• Boje K M. Nitric oxide neurotoxicity in neurodegenerative diseases. Front Biosci 2004; 9: 763–776
   PubMed Web of Science ®Google Scholar
• Kang Y-C, Kim P-K, Choi B-M, Chung H-T, Ha K-S, Kwon Y-G, Kim Y-M. Regulation of programmed cell death in neuronal cells by nitric oxide. In Vivo 2004; 18: 367–376
   PubMed Web of Science ®Google Scholar
• Keynes R G, Garthwaite J. Nitric oxide and its role in ischaemic brain injury. Curr Mol Med. 2004; 4: 179–191
   PubMed Web of Science ®Google Scholar
• Duncan A J, Heales S JR. Nitric oxide and neurological disorders. Mol Aspects Med 2005; 26: 67–96
   PubMedGoogle Scholar
• Bolanos J P, Garcia-Nogales P, Almeida A. Provoking neuroprotection by peroxynitrite. Curr Pharm Des. 2004; 10: 867–877
   PubMed Web of Science ®Google Scholar
• Taguchi R, Shirakawa H, Yamaguchi T, Kume T, Katsuki H, Akaike A. Nitric oxide-mediated effect of nipradilol and an α - and β -adrenergic blocker on glutamate neurotoxicity in rat cortical cultures. Eur J Pharmacol. 2006; 535: 86–94
   PubMed Web of Science ®Google Scholar
• Farinelli S E, Park D S, Greene L A. Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. J Neurosci. 1996; 16: 2325–2334
   PubMed Web of Science ®Google Scholar
• Kim Y-M, Chung H-T, Kim S-S, Han J-A, Yoo Y-M, Kim K-M, Lee G-H, Yun H-Y, Green A, Li L, Simmons R L, Billiar T R. Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J Neurosci. 1999; 19: 6740–6747
   PubMed Web of Science ®Google Scholar
• Allsopp T E. Transduction of survival signals in neurons—take your PIK?. Trends Neurosci 2000; 23: 593
   PubMed Web of Science ®Google Scholar
• Zhao H, Sapolsky R M, Steinberg G K. Phosphatidylinositol-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 2006; 34: 249–270
   PubMed Web of Science ®Google Scholar
• Ha K S, Kim K M, Kwon Y G, Bai S K, Nam W D, Yoo Y M, Kim P K, Chung H T, Billiar T R, Kim Y M. Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation. FASEB J 2003; 17: 1036–1047
   PubMed Web of Science ®Google Scholar
• Delgado-Esteban M, Martin-Zanca D, Andres-Martin L, Almedida A, Bolanos J P. J Neurochem 2007; 102: 194–205
   PubMed Web of Science ®Google Scholar
• Aviles-Trigueros M, Mayor-Torroglosa S, Garcia-Aviles A, Lafuente M P, Rodriguez M E, Miralles de Imperial J, Villegas-Perez M P, Vidal-Sanz M. Transient ischemia of the retina results in massive degeneration of the retinotectal projection: Long-term neuroprotection with brimonidine. Exp Neurol 2003; 184: 767–777
   PubMed Web of Science ®Google Scholar
• Manabe S, Lipton S A. Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina. Invest Ophthalmol Vis Sci 2003; 44: 385–392
   PubMed Web of Science ®Google Scholar
• Tzekov R, Arden G B. The electroretinogram in diabetic retinopathy. Surv Ophthalmol 1999; 44: 53–60
   PubMed Web of Science ®Google Scholar
• Klemp K, Sander B, Brockhoff P B, Vaag A, Lund-Anderson H, Larsen M. The multifocal ERG in diabetic patients without retinopathy during euglycemic clamping. Invest Ophthalmol Vis Sci. 2005; 46: 2620–2626
   PubMed Web of Science ®Google Scholar
• Verrotti A, Lobefalo L, Petitti M T, Mastropasqua L, Morgese G, Chiarelli F, Gallenga P E. Relationship between contrast sensitivity and metabolic control in diabetics with and without retinopathy. Ann Med. 1998; 30: 369–374
   PubMed Web of Science ®Google Scholar
• Lopes d e, Faria J M, Katsumi O, Cagliero E, Nathan D, Hirose T. Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus. Graefes Arch Clin Exp Ophthalmol. 2001; 239: 643–648
   PubMed Web of Science ®Google Scholar
• Chihara E, Matsuoka T, Ogura Y, Matsumura M. Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy. Ophthalmology 1993; 100: 1147–1151
   PubMed Web of Science ®Google Scholar
• Takahashi H, Goto T, Shoji T, Tanito M, Park M, Chihara E. Diabetes-associated retinal nerve fiber damage evaluated with scanning laser polarimetry. Am J Ophthalmol 2006; 142: 88–94
   PubMed Web of Science ®Google Scholar
• Lieth E, Barber A J, Xu B, Dice C, Ratz M J, Tanase D, Strother J M. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 1998; 47: 815–820
   PubMed Web of Science ®Google Scholar
• Rungger-Brandle E, Dosso A A, Leuenberger P M. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2000; 41: 1971–1980
   PubMed Web of Science ®Google Scholar
• Barber A J, Antonetti D A, Gardner T W. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. Invest Ophthalmol Vis Sci 2000; 41: 3561–3568
   PubMed Web of Science ®Google Scholar
• Li Q, Puro D G. Diabetes-induced dysfunction of the glutamate transporter in retinal Muller cells. Invest Ophthalmol Vis Sci 2002; 43: 3109–3116
   PubMed Web of Science ®Google Scholar
• Gaucher D, Chiappore J-A, Pâques M, Simonutti M, Boitard C, Sahel J A, Massin P, Picaud S. Microglial changes occur without neural cell death in diabetic retinopathy. Vision Res 2007; 47: 612–623
   PubMed Web of Science ®Google Scholar
• Feit-Leichman R A, Kinouchi R, Takeda M, Fan Z, Mohr S, Kern T S, Chen D F. Vascular damage in a mouse model of diabetic retinopathy: Relation to neuronal and glial changes. Invest Ophthalmol Vis Sci. 2005; 46: 4281–4287
   PubMed Web of Science ®Google Scholar
• Nakamura M, Kanamori A, Negi A. Diabetes mellitus as a risk factor for glaucomatous optic neuropathy. Ophthalmologica. 2005; 219: 1–10
   PubMed Web of Science ®Google Scholar
• Chen W, Jump D B, Grant M B, Esselman W J, Busik J V. Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 2003; 44: 5016–5022
   PubMed Web of Science ®Google Scholar
• Joussen A M, Poulaki V, Le M L, Koizumi K, Esser C, Janicki H, Schraemeyer U, Kociok N, Fauser S, Kirchhof B, Kern T S, Adamis A P. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004; 18: 1450–1452
   PubMed Web of Science ®Google Scholar
• Ono R, Kakehashi A, Ito Y, Sugi N, Makino S, Kobayashi E, Hakamada Y, Takagi Y, Kitazume Y, Kawakami M. Effect of topical nipradilol on retinal microvascular leukocyte adhesion in diabetic rats. Ophthalmic Res 2006; 38: 270–273
   PubMed Web of Science ®Google Scholar